Treatment outcome of ductal carcinoma in situ patients treated with postoperative radiation therapy |
Lim, Yu Jin
(Department of Radiation Oncology, Seoul National University College of Medicine)
Kim, Kyubo (Department of Radiation Oncology, Seoul National University College of Medicine) Chie, Eui Kyu (Department of Radiation Oncology, Seoul National University College of Medicine) Han, Wonshik (Department of Surgery, Seoul National University College of Medicine) Noh, Dong Young (Department of Surgery, Seoul National University College of Medicine) Ha, Sung W. (Department of Radiation Oncology, Seoul National University College of Medicine) |
1 | Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27:5319-24. DOI ScienceOn |
2 | Kim KJ, Huh SJ, Park W, et al. Treatment outcome and analysis of the prognostic factors of ductal carcinoma in situ treated with breast conserving surgery and radiotherapy. J Korean Soc Ther Radiol Oncol 2004;22:11-6. |
3 | Di Saverio S, Catena F, Santini D, et al. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat 2008;109:405-16. DOI ScienceOn |
4 | Dunne C, Burke JP, Morrow M, Kell MR. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009;27: 1615-20. DOI ScienceOn |
5 | Wang SY, Chu H, Shamliyan T, et al. Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst 2012;104:507-16. DOI |
6 | Wong P, Lambert C, Agnihotram RV, David M, Duclos M, Freeman CR. Ductal carcinoma in situ: the influence of the radiotherapy boost on local control. Int J Radiat Oncol Biol Phys 2012;82:e153-8. DOI ScienceOn |
7 | Rakovitch E, Narod SA, Nofech-Moses S, et al. Impact of boost radiation in the treatment of ductal carcinoma in situ: a population-based analysis. Int J Radiat Oncol Biol Phys 2013;86:491-7. DOI ScienceOn |
8 | Motwani SB, Goyal S, Moran MS, Chhabra A, Haffty BG. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194. Cancer 2011;117:1156-62. DOI ScienceOn |
9 | Masson S, Bahl A. The management of ductal carcinoma in situ: current controversies and future directions. Clin Oncol (R Coll Radiol) 2013;25:275-82. DOI ScienceOn |
10 | Siziopikou KP. Ductal carcinoma in situ of the breast: current concepts and future directions. Arch Pathol Lab Med 2013; 137:462-6 DOI ScienceOn |
11 | Korean Breast Cancer Society. Breast Cancer Facts & Figures. Seoul: Korean Breast Cancer Society; 2013. |
12 | Owen D, Tyldesley S, Alexander C, et al. Outcomes in patients treated with mastectomy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 2013;85:e129-34. DOI ScienceOn |
13 | Hwang ES. The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy. J Natl Cancer Inst Monogr 2010;2010:197-9. DOI ScienceOn |
14 | Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011;103:478-88. DOI ScienceOn |
15 | Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 2008;26:1247-52. DOI ScienceOn |
16 | Donker M, Litiere S, Werutsky G, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 2013;31:4054-9. DOI ScienceOn |
17 | Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 2006;24:1031-6. DOI ScienceOn |
18 | Bane A. Ductal carcinoma in situ: what the pathologist needs to know and why. Int J Breast Cancer 2013;2013:914053. |
19 | Cuzick J, Sestak I, Pinder SE, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011;12:21-9. DOI ScienceOn |
20 | McCormick B, Winter K, Hudis C, et al. RTOG 9804: a prospective randomized trial for "good risk" ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS). In: 2012 American Society of Clinical Oncology Annual Meeting; 2012 Jun 1-5; Chicago, IL, USA. Alexandria, VA: ASCO; 2012. |